Prenosis Inc. Receives BARDA Contract to Study Utility of Its Sepsis Diagnostic Tool
The Sepsis ImmunoScore™ is a pathogen-agnostic, host-based digital diagnostic that uses Artificial Intelligence/Machine Learning (AI/ML) to predict sepsis based on a combination of clinical parameters and protein biomarkers CHICAGO, June 7, 2023 /PRNewswire/ — Prenosis Inc., an artificial intelligence company... Read More →
RevBio is Awarded a $2 Million Grant to Advance the Development of its Novel Dental Adhesive Bone Scaffold Product
This grant will fund the completion of the company’s pre-clinical development program and pave the way to initiate a clinical trial. LOWELL, Mass.–(BUSINESS WIRE)–RevBio, Inc., announced that it has been awarded a $2 million Phase II Small Business Innovation Research... Read More →
Candesant Biomedical Announces $35M in Series B Financing to Advance Commercialization of Brella™, the First and Only FDA-cleared 3-Minute SweatControl Patch™
NASHVILLE, Tenn., June 6, 2023 /PRNewswire/ — Candesant Biomedical, Inc. (“Candesant”), a private medical device company focused on the development and commercialization of non-invasive treatments for hyperhidrosis or excessive sweating, today announced the closing of a Series B financing, raising... Read More →
Xtremedy Medical: Zapping wound infections to accelerate healing
Founded in 2020, Galway-based Xtremedy is raising seed funding to start clinical trials for its novel medical device to treat diabetic foot infections. Lyn Markey first met Camille O’Malley at the BioInnovate Ireland fellowship programme in 2018, as part of... Read More →
NeuroFlow, Atlantic Health System partner to launch collaborative care model
Sixteen accountable care organization sites will utilize NeuroFlow’s platform to support clinical teams as they screen behavioral health patients. Pennsylvania-based NeuroFlow, a behavioral health company, has partnered with New Jersey-based Atlantic Health System to advance a collaborative care model for... Read More →
LEADOPTIK Raises $5 Million in Series Seed Funding to Advance Early Lung Cancer Detection with Cutting-Edge Imaging Technology
SAN JOSE, Calif., May 22, 2023 /PRNewswire/ — LEADOPTIK Inc., a Silicon Valley-based medical imaging company today announced that it has raised $5 million in an oversubscribed series seed funding, led by MetaVC Partners with participation from SOSV, Sony Innovation... Read More →
Moon Surgical Appoints Fred Moll, MD, as Board Chair and Raises Additional $55.4 Million in New Funding with Leading Investors Sofinnova Partners and NVIDIA
PARIS, FRANCE and SAN FRANCISCO, CA / ACCESSWIRE / May 17, 2023 / Moon Surgical, a French-American pioneer in collaborative robotics, announced today that it has secured $55.4 million in additional funding to support the continued development and planned commercialization of... Read More →
CORRECTING and REPLACING Universal DX Presents Data from Large, 1,000-patient, Multi-Cohort Study Proving 93% Sensitivity for Colorectal Cancer and 54% Sensitivity for Advanced Adenoma at 92% Specificity
Findings highlight company’s approach is highly accurate for early-stage (I-II) detection: CRCs (91% sensitivity) and AA (54% sensitivity) at 92% specificity Data offer hope for the future of blood-based early cancer detection Universal Diagnostics (Universal DX), a bioinformatics and multi-omics... Read More →
Gaylord Specialty Healthcare First in Nation to Adopt Ground-Breaking Pharyngeal Electrical Stimulation Technology to Treat Patients with Dysphagia featuring Phagenesis
WALLINGFORD, Conn., May 9, 2023 /PRNewswire/ — Gaylord Specialty Healthcare, a nonprofit rehabilitation-focused healthcare system, is proud to announce that it is the first healthcare organization in the nation to use the Phagenyx® Neurostimulation System from Phagenesis, Ltd. to treat dysphagia among stroke... Read More →
CardiaCare Names Ken Nelson Chairman of its Board of Directors
Digital health and medtech leader brings 20 years of cardiac innovation and commercialization experience to startup developing AI powered neuromodulation wearable for non-invasive atrial fibrillation treatment REHOVOT, Israel, May 8, 2023 /PRNewswire/ — CardiaCare, a clinical stage digital therapeutic company developing the world’s first... Read More →